tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Imron Zafar, 17 are a BUY (53.13%), 15 are a HOLD (46.88%).
Analyst Imron Zafar, currently employed at DEUTSCHE BANK, carries an average stock price target met ratio of 100% that have a potential upside of 11.01% achieved within 158 days.
Imron Zafar’s has documented 65 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SWAV, Shockwave Medical at 08-Apr-2024.
Analyst best performing recommendations are on ISRG (INTUITIVE SURGICAL).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL) at 7/18/2014. The price target of $51.67 was fulfilled within 6 days with a profit of $8.67 (20.16%) receiving and performance score of 33.6.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$565
$37.39 (7.09%)
$440
1 months 3 days ago
(18-Oct-2024)
3/4 (75%)
$43.85 (8.41%)
137
Buy
$535
$7.39 (1.40%)
$518
1 months 3 days ago
(18-Oct-2024)
16/16 (100%)
$13.85 (2.66%)
177
Buy
$525
$-2.61 (-0.49%)
$475
1 months 3 days ago
(18-Oct-2024)
27/27 (100%)
$3.85 (0.74%)
216
Buy
$538
$10.39 (1.97%)
$495
1 months 3 days ago
(18-Oct-2024)
28/29 (96.55%)
$16.85 (3.23%)
157
$490
$-37.61 (-7.13%)
$475
1 months 3 days ago
(18-Oct-2024)
18/23 (78.26%)
$-31.15 (-5.98%)
72
What Year was the first public recommendation made by Imron Zafar?
